ARTICLE | Finance
Ebb & Flow
August 11, 2008 7:00 AM UTC
The drought in follow-on financings, which began in late June, ended with a bang in August with three big deals.
Microarray company Illumina (NASDAQ:ILMN) raised $306.3 million, putting it in the number one spot this year. Neurology play Acorda (NASDAQ:ACOR) raised $114 million while cancer, autoimmune and endocrine company Incyte (NASDAQ:INCY) raised $108.7 million, ranking them number four and five...